Worldwide Joint Reconstruction Device Industry to 2026 - Escalating Demand for Minimally Invasive Diagnostic and Surgical Techniques Presents Opportunities
DUBLIN, Oct. 14, 2021 /PRNewswire/ -- The "Joint Reconstruction Device Market Research Report by Type, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Joint Reconstruction Device Market size was estimated at USD 12.30 billion in 2020, is expected to reach USD 15.04 billion in 2021, and projected to grow at a CAGR of 22.62% reaching USD 41.83 billion by 2026.
Market Statistics
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Competitive Strategic Window
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Joint Reconstruction Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Joint Reconstruction Device Market, including Aesculap Implant Systems, Inc., Arthrex, Inc., B. Braun Melsungen AG, CONMED Corporation, Corin Group PLC, Covidien plc, DePuy Synthes, Inc., DJO Global Inc., Donjoy Inc., Globus Medical, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kyocera Corp., Medtronic PLC, MicroPort Scientific Corp., NuVasive, Inc., OMNI life science, Inc., Smith & Nephew PLC, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Joint Reconstruction Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Joint Reconstruction Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Joint Reconstruction Device Market?
4. What is the competitive strategic window for opportunities in the Global Joint Reconstruction Device Market?
5. What are the technology trends and regulatory frameworks in the Global Joint Reconstruction Device Market?
6. What is the market share of the leading vendors in the Global Joint Reconstruction Device Market?
7. What modes and strategic moves are considered suitable for entering the Global Joint Reconstruction Device Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing prevalence of orthopedic diseases and associated risk factors
5.2.2. Increasing number of outpatient joint replacement procedures
5.2.3. Ongoing research and development activity on improving robotically-assisted surgeries and bionic implants
5.2.4. Investment by companies in research and development for bigger joint implants
5.3. Restraints
5.3.1. Decreasing reimbursement options
5.3.2. Expensive joint replacement procedures and implants
5.4. Opportunities
5.4.1. Escalating demand for minimally invasive diagnostic and surgical techniques
5.4.2. Increase in geriatric population in Asia Pacific countries
5.4.3. Value-based joint replacements are prompting technology innovation in the space
5.5. Challenges
5.5.1. Biocompatibility issues
6. Joint Reconstruction Device Market, by Type
6.1. Introduction
6.2. Ankle Replacement
6.3. Digits Replacement
6.4. Elbow Replacement
6.5. Shoulder Replacement
6.6. Wrist Replacement
7. Joint Reconstruction Device Market, by Application
7.1. Introduction
7.2. Arthrodesis
7.3. Arthroscopy
7.4. Joint Replacement Surgery
7.5. Osteotomy
7.6. Resurfacing Surgery
7.7. Small Joint Surgery
8. Americas Joint Reconstruction Device Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Joint Reconstruction Device Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Joint Reconstruction Device Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Aesculap Implant Systems, Inc.
12.2. Arthrex, Inc.
12.3. B. Braun Melsungen AG
12.4. CONMED Corporation
12.5. Corin Group PLC
12.6. Covidien plc
12.7. DePuy Synthes, Inc.
12.8. DJO Global Inc.
12.9. Donjoy Inc.
12.10. Globus Medical
12.11. Integra LifeSciences Corporation
12.12. Johnson & Johnson Services, Inc.
12.13. Kyocera Corp.
12.14. Medtronic PLC
12.15. MicroPort Scientific Corp.
12.16. NuVasive, Inc.
12.17. OMNI life science, Inc.
12.18. Smith & Nephew PLC
12.19. Stryker Corporation
12.20. Wright Medical Group N.V.
12.21. Zimmer Biomet Holdings, Inc.
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/u4jo8v
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:SOURCE Research and Markets
